Oculis Holding AG ( OCS) - Stock Earnings
OCS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
OCS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -29.4 million USD | — USD |
| 2026Q1 | -36.8 million USD | — USD |
| 2026Q2 | -12.3 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
OCS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -105.6 million USD | 1.1 million USD |
| 2024 | -94.9 million USD | 758581 USD |
| 2025 | -119.1 million USD | — USD |
| 2026 Est. | — | — |
OCS
Price: $7.29
52 week price:
Earnings Per Share: -1.72 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Market Capitalization: 499.1 million